Literature DB >> 21673728

X inactivation: a histone protects from reprogramming by the frog.

Anton Wutz1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21673728      PMCID： PMC3116290          DOI： 10.1038/emboj.2011.172

Source DB:  PubMed          Journal:  EMBO J        ISSN： 0261-4189            Impact factor:   11.598


× No keyword cloud information.
  11 in total

1.  Conditional deletion of Xist disrupts histone macroH2A localization but not maintenance of X inactivation.

Authors:  G Csankovszki; B Panning; B Bates; J R Pehrson; R Jaenisch
Journal:  Nat Genet       Date:  1999-08       Impact factor: 38.330

2.  The macro domain is an ADP-ribose binding module.

Authors:  Georgios I Karras; Georg Kustatscher; Heeran R Buhecha; Mark D Allen; Céline Pugieux; Fiona Sait; Mark Bycroft; Andreas G Ladurner
Journal:  EMBO J       Date:  2005-05-19       Impact factor: 11.598

3.  Developmental changes in histone macroH2A1-mediated gene regulation.

Authors:  Lakshmi N Changolkar; Carl Costanzi; N Adrian Leu; Dannee Chen; K John McLaughlin; John R Pehrson
Journal:  Mol Cell Biol       Date:  2007-01-22       Impact factor: 4.272

4.  Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution.

Authors:  Nimet Maherali; Rupa Sridharan; Wei Xie; Jochen Utikal; Sarah Eminli; Katrin Arnold; Matthias Stadtfeld; Robin Yachechko; Jason Tchieu; Rudolf Jaenisch; Kathrin Plath; Konrad Hochedlinger
Journal:  Cell Stem Cell       Date:  2007-06-07       Impact factor: 24.633

5.  Histone macroH2A1 is concentrated in the inactive X chromosome of female mammals.

Authors:  C Costanzi; J R Pehrson
Journal:  Nature       Date:  1998-06-11       Impact factor: 49.962

6.  Stable X chromosome inactivation involves the PRC1 Polycomb complex and requires histone MACROH2A1 and the CULLIN3/SPOP ubiquitin E3 ligase.

Authors:  Inmaculada Hernández-Muñoz; Anders H Lund; Petra van der Stoop; Erwin Boutsma; Inhua Muijrers; Els Verhoeven; Dmitri A Nusinow; Barbara Panning; York Marahrens; Maarten van Lohuizen
Journal:  Proc Natl Acad Sci U S A       Date:  2005-05-16       Impact factor: 11.205

7.  Changes in the nuclear deposition of histone H2A variants during pre-implantation development in mice.

Authors:  Buhe Nashun; Masashi Yukawa; Honglin Liu; Tomohiko Akiyama; Fugaku Aoki
Journal:  Development       Date:  2010-10-13       Impact factor: 6.868

8.  Reversal of X-inactivation in female mouse somatic cells hybridized with murine teratocarcinoma stem cells in vitro.

Authors:  N Takagi; M A Yoshida; O Sugawara; M Sasaki
Journal:  Cell       Date:  1983-10       Impact factor: 41.582

9.  The histone variant macroH2A suppresses melanoma progression through regulation of CDK8.

Authors:  Avnish Kapoor; Matthew S Goldberg; Lara K Cumberland; Kajan Ratnakumar; Miguel F Segura; Patrick O Emanuel; Silvia Menendez; Chiara Vardabasso; Gary Leroy; Claudia I Vidal; David Polsky; Iman Osman; Benjamin A Garcia; Eva Hernando; Emily Bernstein
Journal:  Nature       Date:  2010-12-23       Impact factor: 49.962

10.  Histone variant macroH2A confers resistance to nuclear reprogramming.

Authors:  Vincent Pasque; Astrid Gillich; Nigel Garrett; John B Gurdon
Journal:  EMBO J       Date:  2011-05-06       Impact factor: 11.598
View more
  3 in total

Review 1.  Epigenetic stability of repressed states involving the histone variant macroH2A revealed by nuclear transfer to Xenopus oocytes.

Authors:  Vincent Pasque; Richard P Halley-Stott; Astrid Gillich; Nigel Garrett; John B Gurdon
Journal:  Nucleus       Date:  2011-11-01       Impact factor: 4.197

Review 2.  Epigenomics of cancer - emerging new concepts.

Authors:  Melanie R Hassler; Gerda Egger
Journal:  Biochimie       Date:  2012-05-17       Impact factor: 4.079

3.  A genetic approach to the recruitment of PRC2 at the HoxD locus.

Authors:  Patrick Schorderet; Nicolas Lonfat; Fabrice Darbellay; Patrick Tschopp; Sandra Gitto; Natalia Soshnikova; Denis Duboule
Journal:  PLoS Genet       Date:  2013-11-07       Impact factor: 5.917
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.